ライフサイエンスコーパス: MSM

1 MSM and PWID were recruited across India using responden

2 MSM diagnosed with acute and early HIV infection were re

3 MSM in our study often used antibiotics without a prescr

4 MSM present with gastroenteritis from varied pathogens,

5 MSM with primary syphilis who did not practice receptive

6 MSM, compared to MSW, had higher CD8+ counts (551 vs. 43

7 : [47.7, 111.9]) gonorrhea cases per 100,000 MSM population each year with the first-line antibiotics

8 .1 (54.3, 127.3) gonorrhea cases per 100,000 MSM population each year without increasing the incidenc

9 Among 1159 MSM, 583 (50.3%) had 844 CT and 843 GC tests during 2016

10 The study included 1256 MSM, 1090 of whom (86.8%) were not taking PrEP.

11 Urine was collected from NGU cases (129 MSM; 121 MSW) and controls (70 MSM; 114 MSW) attending a

12 ategy to achieve HIV viral suppression, 1305 MSM were screened across four geographically diverse US

13 From 147 MSM who completed the questionnaire, there were an assoc

14 nd of the micro-elimination program, 176/190 MSM (93%) were cured, and the HCV incidence rate decline

15 Ten patients were diagnosed with IASCC: 2 (MSM) in the screening group and 8 (4 MSM, 2 MSW, and 2 w

16 tween April 14, 2018, and June 30, 2018, 230 MSM were recruited.

17 Among 235 MSM tested (268 episodes), 131 had 151 episodes with pos

18 onducted a retrospective cohort study of 235 MSM who underwent multiplex stool polymerase chain react

19 ge-matched pairs for a total sample of 1,268 MSM of 1,700 MSM with available data.

20 Among 290 MSM initiating PrEP, 43.1% (n = 125) were screened per g

21 Among 299 MSM, abnormal cytology was detected in 161 (54%) MSM and

22 72 pharynx); 9.4% infected females and 67.3% MSM were urogenital negative.

23 In total, 37 MSM PWH were included and followed for a median of 23 mo

24 13 sexual behavior stigma items among 10,396 MSM across 8 sub-Saharan African countries and the Unite

25 SCC: 2 (MSM) in the screening group and 8 (4 MSM, 2 MSW, and 2 women) in the nonscreening group.

26 Of 4257 MSM recorded in the SHCS database, we screened 3722 (87%

27 We recruited 4994 MSM from 5 states across India using respondent-driven s

28 Nearly 1 in 5 MSM screened for HPTN 078 have been infected with HCV.

29 Of 1793 participants (1284 females, 509 MSM), 116 had NG detected (75 urogenital site, 83 rectum

30 Of 1793 participants (1284 females, 509 MSM), 116 had NG detected (75 urogenital, 83 rectum, 72

31 A total of 532 MSM completed 1880 mSTUDY study visits between August 20

32 abnormal cytology was detected in 161 (54%) MSM and was associated with the presence of any 9v HR-HP

33 There were 559 MSM diagnosed with primary (n = 338) or secondary (n = 2

34 actures and 25 cases of ESRD for the 123 610 MSM receiving PrEP, with an ICER of more than $7 million

35 In 65 MSM, including 57 human immunodeficiency virus (HIV)-inf

36 GU cases (129 MSM; 121 MSW) and controls (70 MSM; 114 MSW) attending a Seattle STD clinic.

37 irs for a total sample of 1,268 MSM of 1,700 MSM with available data.

38 65; 95% confidence interval [CI], 0.55-0.76; MSM models: HR, 0.54; 95% CI, 0.40-0.73) and DOACs versu

39 3 pharynx); 13.1% infected females and 71.8% MSM were urogenital negative.

40 We screened 3'715/4'640 (80%) MSM and identified 177 with replicating HCV infections (

41 We re-screened 2'930/3'538 (83%) MSM with a prior negative HCV-RNA and identified 13 (0.4

42 AC (PS matched: HR, 0.68; 95% CI, 0.50-0.93; MSM models: HR, 0.50; 95% CI, 0.31-0.81).

43 Of the 1287 (99%) MSM with HCV antibody results, median age was 41, 69% we

44 iveness of HPV vaccination among young adult MSM.

45 nalities in sexual behavior stigma affecting MSM across sub-Saharan Africa and the United States, whi

46 with incident CT (GC) included younger age, MSM, and prior diagnoses of sexually transmitted disease

47 merging, the WHO target is achievable if all MSM attending sexual health clinics receive a vaccine of

48 man herpesviruses were more prevalent in all MSM groups (P < .001).

49 Implementing PrEP in all MSM would avert 75.2% HIV infections and facilitate a ga

50 Among MSM aged 40-49 years, blacks spent 9.8% (95% CI, 2.4%-16

51 Among MSM, there was evidence of a synergistic negative associ

52 d between September 2018 and June 2019 among MSM receiving community-based human immunodeficiency vir

53 haryngeal N. gonorrhoeae were assessed among MSM routinely universally screened using backward multiv

54 th sexual risk and prevention behavior among MSM.

55 agement with the HIV treatment cascade among MSM.

56 ic cross-sectional study was conducted among MSM recruited in 4 Togolese cities.

57 vior stigma cut across social contexts among MSM in the 9 countries.

58 MP was more often detected among MSM than MSW with urethritis.

59 ith an unusual hrHPV type distribution among MSM, highlighting the critical need of implementation of

60 suggests that PrEP was more effective among MSM in Thailand than in the United States as a result of

61 reinfection remains a frequent finding among MSM in Germany.

62 o assess the causes of gastroenteritis among MSM living with and without human immunodeficiency virus

63 used to simulate annual HIV incidence among MSM cohorts.

64 n was protective against HIV infection among MSM in countries of low and middle income (0.58, 0.41-0.

65 The prevalence of MG infection among MSM on PrEP was high and its incidence was not decreased

66 depression and physical function loss among MSM.

67 etection of HI was associated with NGU among MSM (12% vs. 3%, p=0.036) and MSW (17% vs. 1%, p<0.001),

68 58, 0.41-0.83; k=23; I(2)=77%) but not among MSM in high-income countries (0.99, 0.90-1.09; k=20; I(2

69 ), but MP was associated with NGU only among MSM (13% vs. 1%, p=0.004).

70 Subtype C predominated among MSM living in France.

71 ehavior and greater acceptance of PrEP among MSM who used Grindr, Grindr may provide a useful platfor

72 on-based HCV micro-elimination program among MSM living with HIV was feasible and resulted in a stron

73 allenged by high HCV reinfection rates among MSM.

74 Medical records among MSM initiating PrEP between 30 September 2015 and 31 Mar

75 d and systematic screening for HCV-RNA among MSM from the SHCS.

76 between 2017 and 2019 on STI screening among MSM across the U.S., stratified by current, prior, and n

77 , routine HCV counseling and screening among MSM is important.

78 racteristics associated with screening among MSM PrEP users in Baltimore City, Maryland.

79 racteristics associated with screening among MSM PrEP users in Baltimore City, Maryland.

80 valent infection of HIV and other STIs among MSM were included.

81 roportion of cases presenting symptoms among MSM in the US.

82 ke of gonorrhoea and chlamydia testing among MSM.

83 multivariable logistic regression analysis, MSM were more likely to present with secondary rather th

84 ositivity was high in MSM with HIV (20%) and MSM without HIV (17%) (P=0.12) and was higher in those r

85 ixed between HET/MSM (7%), HET/FSW (5%), and MSM/FSW (3%) sequences.

86 In 2017 FSW and MSM together accounted for 9.3% of prevalent cases.

87 Strengthening efforts targeting FSW and MSM, and identification of other risk populations e.g. a

88 low, but prevalence remains high in FSW and MSM.

89 April 2005), and that Guangdong province and MSM are major hubs for the spread of the HIV-1 CRF55_01B

90 health and STD prevention among PLWH who are MSM, research regarding the added value of CT and GC tes

91 median exposure 40% at PWID sites and 24% at MSM sites).

92 ulation and rising HIV incidence among Black MSM, who have historically been more likely to acquire H

93 However, Black MSM in San Francisco continue to have higher HIV inciden

94 6-month testing was cost-effective for both MSM (incremental cost-effectiveness ratio [ICER], $1000/

95 prevent sexually acquired HCV infections by MSM using PrEP.

96 outcome was the number of HIV tests taken by MSM participants, and the secondary outcome was the numb

97 he new F variant was identified in Caucasian MSM and associated with severe KSHV disease, suggesting

98 Its prevalence was 4.5% in Caucasian MSM, and it was absent in other epidemiological groups.

99 ly increased testing frequency among Chinese MSM and effectively enlarged HIV testing coverage by enh

100 ns on frequency of HIV testing among Chinese MSM and their sexual partners.

101 This could be because Chinese MSM may not report such risk due to HIV/AIDS-related sti

102 e simulated HIV transmission among cisgender MSM in Rhode Island to determine the impacts of PrEP imp

103 dence in the broader population of cisgender MSM.

104 to initiate PrEP compared to other cisgender MSM.

105 sion scenario where 15% of at-risk cisgender MSM used PrEP, the total number of new HIV infections wa

106 Future studies should consider MSM status in gut microbiome analyses.

107 he other group is much smaller, but contains MSM who are more likely to be at high infection risk.

108 ces and a different epidemiological context (MSM vs African population).

109 esigned longitudinal studies differentiating MSM only and bisexual men are needed to clarify the effe

110 After excluding MSM-associated microbiota traits and adjusting for confo

111 in opioid agonist treatment centres and five MSM centres within government-sponsored health services)

112 For MSM, anal HPV16 prevalence was significantly higher from

113 e (adjusted prevalence ratio [aPR], 1.14 for MSM; 1.41 for PWID) and higher HIV treatment literacy (a

114 higher HIV treatment literacy (aPR, 1.58 for MSM; 3.04 for PWID) were positively associated with vira

115 n Harlem compared with 90%, 85%, and 79% for MSM in Bangkok.

116 in Harlem compared with 90%, 85% and 79% for MSM in Bangkok.

117 t can harbor asymptomatic infections and for MSM in Southeast states where the STI burden is substant

118 aily, time-driven, and event-driven PrEP for MSM in Harlem compared with 90%, 85% and 79% for MSM in

119 aily, time-driven, and event-driven PrEP for MSM in Harlem compared with 90%, 85%, and 79% for MSM in

120 Differences were most pronounced for MSM with >10 recent sex partners, and partly explained b

121 essitates improved measurement of stigma for MSM around the world.

122 ylaxis (PrEP) and HIV testing strategies for MSM and PWID in India.

123 al and economic outcomes of 7 strategies for MSM/PWID, including status quo; a 1-time HIV test; routi

124 The hotspots for MSMs were central DC and non-MSM in south DC.

125 multidrug-resistant Campylobacter coli from MSM in Seattle and Montreal.

126 erall growth kinetics are then computed from MSM simulations.

127 al, pharyngeal, and urine (APU) samples from MSM attending the sexually transmitted infections clinic

128 Of the 658 sequences, 131 (20%) were from MSM, 58 (9%) IDU, 109 (17%) FSW, and 360 (55%) HET.

129 Results derived from MSMs (HR = 0.44, 95% CI: 0.32, 0.61) and SNAFTMs (HR = 0

130 PrEP was evaluated in both the general MSM and high-risk MSM populations and was assumed to red

131 he remaining clusters were mixed between HET/MSM (7%), HET/FSW (5%), and MSM/FSW (3%) sequences.

132 difficulty was more common among older HIV+ MSM than age-matched HIV- MSM controls and was associate

133 in 32% (15/47) ,with all patients being HIV+MSM and 93% (14/15) having a documented history of sexua

134 n among older HIV+ MSM than age-matched HIV- MSM controls and was associated with higher risk of depr

135 sex with men (MSM) and HIV-uninfected (HIV-) MSM controls reported their difficulty performing 6 visi

136 uired class A infections were detected in hr-MSM only.

137 an IP than qualified lr-MSM and qualified hr-MSM (2 [interquartile range {IQR}, 1-2] vs 3 [IQR, 2-4];

138 Studies were excluded if MSM could not be distinguished from men who have sex wit

139 In MSM models, warfarin (HR, 0.29; 95% CI, 0.09-0.90) and D

140 samples for diagnostic accuracy and cost in MSM and females.

141 amples for diagnostic accuracy, and cost, in MSM and females.

142 ynx, rectum, plus first catch urine (FCU) in MSM and vulvovaginal swabs (VVS) in females, for NG and

143 The microbiology of gastroenteritis in MSM has not been examined since the advent of antiretrov

144 HCV antibody positivity was high in MSM with HIV (20%) and MSM without HIV (17%) (P=0.12) an

145 0.25% (0.18-0.35%)), and 22.7-fold higher in MSM (5.35% (2.74-12.47%) than in lower-risk men (0.24% (

146 prevalence and incidence of MG infection in MSM enrolled in the open-label phase of the ANRS IPERGAY

147 ct, treat, and prevent enteric infections in MSM.

148 , high HCV infection prevalence may occur in MSM without HIV.

149 oped for HIV transmission and progression in MSM aged 15-64 years.

150 The incidence rate in MSM was 9.02 (95% CI, 6.48-12.26) per 100 py, compared t

151 The HCV reinfection incidence rate in MSM was also compared to the incidence rate in the inter

152 ncidence rate for a first HCV reinfection in MSM was similar in the direct-acting antiviral era, comp

153 creening for this variant may be required in MSM, given the severe clinical presentation of associate

154 tivariate analysis, the transmission risk in MSM was the only independent risk factor of HCV reinfect

155 ly explained by higher CMV seroprevalence in MSM.

156 oach to optimize NG/CT screening strategy in MSM.

157 , routine universal oropharyngeal testing in MSM is feasible and warranted, as currently advised in m

158 er are circulating by sexual transmission in MSM populations across diverse geographic locations, sug

159 er are circulating by sexual transmission in MSM populations across diverse geographic locations, sug

160 reased life expectancy by 0.07-0.30 years in MSM; PrEP added approximately 0.90 life-years to status

161 Risk factors for HIV-1 acquisition included MSM status (79%) and methamphetamine use (21%).

162 effective HIV prevention strategy for Indian MSM and PWID.

163 Among 1454 treatment-eligible HIV-infected MSM and 1939 PWID, older age (adjusted prevalence ratio

164 in HCV incidence by 2030 among HIV-infected MSM in Berlin.

165 nd HPV-18 in a French cohort of HIV-infected MSM, aged >=35 years, followed-up annually (n = 438, 201

166 or nontransmission of HIV from the infected MSM to their partners, independently from seminal viral

167 nors had a lower median IP than qualified lr-MSM and qualified hr-MSM (2 [interquartile range {IQR},

168 nvestigation of Mechanically Separated Meat (MSM) samples is presented.

169 among 3.1 million men who have sex with men (MSM) and 1.1 million people who inject drugs (PWID), wit

170 V-infected (HIV+) men who have sex with men (MSM) and HIV-uninfected (HIV-) MSM controls reported the

171 HR-HPV type among men who have sex with men (MSM) and men who have sex with women (MSW) was 74% and 2

172 cteria and NGU in men who have sex with men (MSM) and men who have sex with women (MSW).

173 suppression among men who have sex with men (MSM) and people who inject drugs (PWID) in India.

174 ations, including men who have sex with men (MSM) and transgender women, in Bangkok, Thailand and Har

175 Men who have sex with men (MSM) are at increased risk for sexually transmitted ente

176 Men who have sex with men (MSM) are at risk for sexual transmission of enteric path

177 us (HIV)-positive men who have sex with men (MSM) are at risk of anal squamous cell carcinoma.

178 infections among men who have sex with men (MSM) are being observed in the Western world.

179 Men who have sex with men (MSM) are disproportionately affected by HIV and other se

180 (HIV) risks among men who have sex with men (MSM) are unclear.

181 orkers (FSWs) and men who have sex with men (MSM) carry disproportionately high burdens of HIV.

182 reening among all men who have sex with men (MSM) enrolled in the Swiss HIV Cohort Study.

183 Men who have sex with men (MSM) exhibit a distinct microbiota signature characteriz

184 donor deferral of men who have sex with men (MSM) from an indefinite to a 12-month deferral since the

185 sexual, and other men who have sex with men (MSM) in Africa, where many countries criminalise same-se

186 dly growing among men who have sex with men (MSM) in China, yet HIV testing remains suboptimal.

187 originated among men who have sex with men (MSM) in Guangdong province in January 2003 (April 2000-A

188 Men who have sex with men (MSM) in Hanoi, Vietnam, completed a questionnaire regard

189 ransmission among men who have sex with men (MSM) in the United States.

190 sexual, and other men who have sex with men (MSM) is a foundational element of an effective response

191 eking (OPS) among men who have sex with men (MSM) is associated with increased risk behavior includin

192 n a population of men who have sex with men (MSM) living in France.

193 ion program among men who have sex with men (MSM) living with HIV from the Swiss HIV Cohort Study (SH

194 smission, such as men who have sex with men (MSM) or people who inject drugs (PWID).

195 Third, in men who have sex with men (MSM) participating in the 2017 Centers for Disease Contr

196 delines recommend men who have sex with men (MSM) PrEP users be screened biannually for syphilis and

197 nged the way that men who have sex with men (MSM) seek sex.

198 d for young adult men who have sex with men (MSM) since 2011.

199 ry 3-6 months for men who have sex with men (MSM) using HIV preexposure prophylaxis (PrEP).

200 e-stratified U.S. men who have sex with men (MSM) using PrEP.

201 infections in all men who have sex with men (MSM) who have engaged in unprotected sex.

202 ere obtained from men who have sex with men (MSM) who started antiretroviral therapy (ART) within 1 y

203 different between men who have sex with men (MSM) who transmitted HIV and those who did not transmit

204 plasia (HGAIN) in men who have sex with men (MSM) who were living with human immunodeficiency virus (

205 ng pathogen among men who have sex with men (MSM) with raising rates of antibiotic resistance.

206 lis control among men who have sex with men (MSM) would be improved if we could increase the proporti

207 ia (predominantly men who have sex with men (MSM)) and HIV-negative otherwise comparable controls, bu

208 veness of PrEP in men who have sex with men (MSM), a major risk group emerging in Korea.

209 8213 HIV-negative men who have sex with men (MSM), and 12758 HIV-positive MSM.

210 ex workers (FSW), men who have sex with men (MSM), and lower-risk women and men in Yunnan were identi

211 ting policy is in men who have sex with men (MSM), as routine universal testing data are lacking.

212 us (HIV)-infected men who have sex with men (MSM), but limited data derive from low-and-middle-income

213 ssion networks in men who have sex with men (MSM), injecting drug users (IDU), female sex workers (FS

214 documented among men who have sex with men (MSM), primarily among those with HIV.

215 benefitted White men who have sex with men (MSM), whose population has increased over the past decad

216 such groups among men who have sex with men (MSM).

217 bset of cisgender men who have sex with men (MSM).

218 us (HIV)-infected men who have sex with men (MSM).

219 exual behavior in men who have sex with men (MSM).

220 us (HIV)-positive men who have sex with men (MSM).

221 (MSW) but not in men who have sex with men (MSM).

222 has been noted in men who have sex with men (MSM).

223 atomic site among men who have sex with men (MSM).

224 cal disease among men who have sex with men (MSM).

225 es, largely among men who have sex with men (MSM).

226 6001 HIV positive men-who-have-sex with men (MSMs) and 6077 HIV positives non-MSMs (n=12078) living i

227 sexual behavior (men who have sex with men [MSM] vs non-MSM).

228 with HIV-1 (1596 men-who-have-sex-with-men [MSM], 888 men-who-have-sex-with-women [MSW], 627 women;

229 Additionally, the metal-semiconductor-metal (MSM) photodetector on beta-Ga(2)O(3) layer shows an ultr

230 HIV-related expenditures by US$708 million (MSM) and US$218 million (PWID) over 5 years compared to

231 e sampling to generate a Markov state model (MSM) for a coronavirus-derived peptide (QFKDNVILL), boun

232 .g., a Markov state in a Markov state model [MSM]).

233 tor domains by building Markov state models (MSMs) from an unprecedented two milliseconds of all-atom

234 it solvent to construct Markov State Models (MSMs) of fibril growth.

235 ate use using 1) marginal structural models (MSMs) and 2) G-estimation of structural nested accelerat

236 PS) matching and marginal structural models (MSMs) to account for confounding by indication and time-

237 sion risk after implementation of a 12-month MSM deferral policy.

238 2 years after implementation of the 12-month MSM deferral policy.

239 donors before implementation of the 12-month MSM deferral was estimated at 2.62 cases per 100 000 per

240 odels: maximum projection (MPM), multislice (MSM), and fused (FM).

241 In 368 HIV-negative MSM and 72 HIV-negative MSW T-lymphocyte phenotyping was

242 ts and CD4+/CD8+ ratios between HIV-negative MSM and men who only have sex with women (MSW), and rela

243 tributes to comorbidity risk in HIV-negative MSM requires further study.

244 ansmission from HIV-infected to HIV-negative MSM through chemsex and traumatic sexual practices, lead

245 Sexually active and HIV-negative MSM were recruited from communities and randomly assigne

246 Of 3259 HIV-negative MSM, 19% were currently using PrEP, 6% had used PrEP in

247 IV may, both in PWH and certain HIV-negative MSM, contribute to a low CD4+/CD8+ ratio.

248 ar between HIV-positive MSW and HIV-negative MSM.

249 In the NHBS MSM survey, 27 of 591 respondents (4.8%; 95% CI, 3.2% to

250 he hotspots for MSMs were central DC and non-MSM in south DC.

251 vior (men who have sex with men [MSM] vs non-MSM).

252 MSM hotspots shows plateauing and among non-MSMs showed decline.

253 For non-MSMs we found that aged 12 - 18 (9.025; 3.314, 2.581) an

254 x with men (MSMs) and 6077 HIV positives non-MSMs (n=12078) living in DC, end of 2018.

255 ge of eight partners per year (around 20% of MSM) would improve the cost-effectiveness, averting 78.0

256 testing indicators, 98.4% (81 022/82 332) of MSM would be tested, finding 99.5% (4814/4838) of infect

257 More than 60% of MSM in the United States use the internet and/or smartph

258 In this retrospective analysis of MSM diagnosed with primary or secondary syphilis at Melb

259 increased among PLWH; however, only half of MSM were tested for CT or GC during 2016-2017 and less t

260 One group, containing the majority of MSM, appears comfortable testing for HIV but prefers fac

261 In view of the substantial proportion of MSM in countries of low and middle income who also have

262 Initiating PrEP in a larger proportion of MSM in Korea would prevent more HIV infections, but at a

263 a low HCV prevalence in this large sample of MSM despite a high prevalence of known risk factors, ref

264 This was a retrospective study of MSM-associated Campylobacter in Seattle, Washington and

265 A substantial subpopulation of MSM had incident infection, one-third of whom had a nega

266 l outperformed simpler models including only MSM status and STI positivity.

267 We examined the proportion of HIV-positive MSM tested for syphilis in the past 3, 6, and 12 months

268 HIV-positive MSM were screened for histopathological SILs by means of

269 I]: 69%-73%) of sexually active HIV-positive MSM were tested for syphilis in the past year.

270 e common during follow-up among HIV-positive MSM without dysplasia at baseline.

271 e sex with men (MSM), and 12758 HIV-positive MSM.

272 M from chicken collarbones, 4) high pressure MSM from chicken carcasses and 5) high pressure MSM from

273 from chicken carcasses and 5) high pressure MSM from chicken collarbones.

274 and deboned chicken fillets, 2) low pressure MSM from chicken carcasses, 3) low pressure MSM from chi

275 MSM from chicken carcasses, 3) low pressure MSM from chicken collarbones, 4) high pressure MSM from

276 wn risk clustered within groups who reported MSM risk.

277 luated in both the general MSM and high-risk MSM populations and was assumed to reduce infection risk

278 Initiating PrEP in high-risk MSM with an average of eight partners per year (around 2

279 Focusing PrEP on higher risk MSM and any reduction in PrEP cost would improve cost-ef

280 The regression analysis showed MSM aged 21 - 25 (RR: 3.199, 95% CI: 1.832, 5.586) and n

281 The Vaccine Impact in Men study surveyed MSM and transgender women aged 18-26 years in 3 US citie

282 es into differentiated care models targeting MSM and PWID in low-resource settings is critical to ach

283 a, and selected 22 of these (12 PWID and ten MSM) for a cluster randomised trial on the basis of high

284 longitudinal studies recruiting at least ten MSM, published from Jan 1, 1980, to Oct 10, 2018.

285 The finding that MSM who practiced receptive anal intercourse more common

286 We hypothesized that MSM who practiced receptive anal intercourse were more l

287 By comparing the MSM of the wild-type system with those of the D4A and D4

288 present with secondary syphilis, compared to MSM who did not practice receptive anal intercourse.

289 ment with HCV direct-acting agents (DAAs) to MSM identified with a replicating HCV infection.

290 infected and more recently in HIV-uninfected MSM, especially those receiving pre-exposure prophylaxis

291 pharynx and rectum, plus first catch urine (MSM) and vulvovaginal swabs (females), for NG/CT detecti

292 s the transmission of gonorrhea among the US MSM population, and, to better capture uncertainty in th

293 and in preexposure prophylaxis (PrEP)-using MSM.

294 Utilizing MSMs and SNAFTMs to account for time-varying bisphosphon

295 7) and of 85% (40/47) male, 58% (23/40) were MSM.

296 (40/47) were male, 58% (23/40) of whom were MSM.

297 overall HIV incidence, including among White MSM, is not only explained by the use of TaSP and PrEP,

298 inal justice-related factors than have White MSM.

299 Trends of viral suppression within MSM hotspots shows plateauing and among non-MSMs showed

300 Among the young MSM reporting meth injection in this Los Angeles cohort,